MyMD Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Share-based Payments (Tables)

Share-based Payments (Tables)

9 Months Ended

Sep. 30, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation Warrants Activity

The following table summarizes the warrant activities for the nine months ended September 30, 2015:

						Weighted
						Average
				Weighted		Remaining		Aggregate
	Number of			Average		Contractual		Intrinsic
	Shares			Exercise Price		Term (years)		Value
*Balance at December 31, 2014*		1,989		$	71.76
Granted		-			-
Exercised		-			-
Forfeited		-			-
Canceled/Expired		(1,989	)		71.76
*Balance at September 30, 2015*		-		$	-
*Exercisable as of September 30, 2015*		-		$	-		-	$	-

Summary of Stock Options Activity

The following table summarizes the option activities for the nine months ended September 30, 2015:

					Weighted
					Average
			Weighted		Remaining		Aggregate
	Number of		Average		Contractual		Intrinsic
	Shares		Exercise Price		Term (years)		Value
*Balance at December 31, 2014*		175,000	$	4.98
Granted		-		-
Exercised		-		-
Forfeited		-		-
Canceled/Expired		-		-
*Balance at September 30, 2015*		175,000	$	4.98
*Exercisable as of September 30, 2015*		175,000	$	4.98		3.75	$	-

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details